{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:13:13Z","timestamp":1721934793829},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1245\/s10434-018-7004-6","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T17:55:50Z","timestamp":1543600550000},"page":"336-342","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?"],"prefix":"10.1245","volume":"26","author":[{"given":"Jennifer L.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Muhsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Stempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"issue":"11","key":"7004_CR1","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1245\/s10434-016-5463-1","volume":"23","author":"AV Barrio","year":"2016","unstructured":"Barrio AV, Mamtani A, Edelweiss M, et al. How often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy? Ann Surg Oncol 2016; 23(11):3475\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7004_CR2","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15(7):2483\u201393.","journal-title":"J Clin Oncol"},{"issue":"4","key":"7004_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg 2014; 260(4):608\u201314; (discussion 14\u20136).","journal-title":"Ann Surg"},{"issue":"5","key":"7004_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","volume":"27","author":"JM Classe","year":"2009","unstructured":"Classe JM, Bordes V, Campion L, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 2009; 27(5):726\u201332.","journal-title":"J Clin Oncol"},{"issue":"12","key":"7004_CR5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2005; 23(12):2694\u2013702.","journal-title":"J Clin Oncol"},{"issue":"14","key":"7004_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 2013; 310(14):1455\u201361.","journal-title":"JAMA"},{"issue":"7","key":"7004_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 2013; 14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"3","key":"7004_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol 2015; 33(3):258\u201364.","journal-title":"J Clin Oncol"},{"key":"7004_CR9","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology, Breast Cancer. Version. 1.2018."},{"issue":"10","key":"7004_CR10","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","volume":"19","author":"R Alvarado","year":"2012","unstructured":"Alvarado R, Yi M, Le-Petross H, et al. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 2012; 19(10):3177\u201384.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"7004_CR11","first-page":"893","volume":"9","author":"FE Sharkey","year":"1996","unstructured":"Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996; 9(9):893\u2013900.","journal-title":"Mod Pathol"},{"issue":"4","key":"7004_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"ER Fisher","year":"2002","unstructured":"Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 2002; 95(4):681\u201395.","journal-title":"Cancer"},{"issue":"2","key":"7004_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg 2015; 261(2):378\u201382.","journal-title":"Ann Surg"},{"issue":"4","key":"7004_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/bjs.10626","volume":"105","author":"M Ahmed","year":"2018","unstructured":"Ahmed M, Douek M. Targeted axillary dissection after neoadjuvant therapy in breast cancer. Br J Surg 2018; 105(4):313\u20134.","journal-title":"Br J Surg"},{"issue":"10","key":"7004_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 2016; 34(10):1072\u20138.","journal-title":"J Clin Oncol"},{"issue":"8","key":"7004_CR16","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/cncr.24964","volume":"116","author":"ER Port","year":"2010","unstructured":"Port ER, Patil S, Stempel M, Morrow M, Cody HS 3rd. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Cancer 2010; 116(8):1987\u201391.","journal-title":"Cancer"},{"issue":"Suppl 3","key":"7004_CR17","doi-asserted-by":"publisher","first-page":"S470","DOI":"10.1245\/s10434-015-4698-6","volume":"22","author":"P Subhedar","year":"2015","unstructured":"Subhedar P, Stempel M, Eaton A, Morrow M, Gemignani ML. Do the ACOSOG Z0011 criteria affect the number of sentinel lymph nodes removed? Ann Surg Oncol 2015; 22 Suppl 3:S470\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"7004_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1072-7515(01)00847-X","volume":"192","author":"MD McCarter","year":"2001","unstructured":"McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS 3rd. The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 2001; 192(6):692\u20137.","journal-title":"J Am Coll Surg"},{"issue":"10","key":"7004_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8(10):881\u20138.","journal-title":"Lancet Oncol"},{"issue":"3","key":"7004_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","volume":"261","author":"JC Boughey","year":"2015","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg 2015; 261(3):547\u201352.","journal-title":"Ann Surg"},{"issue":"4","key":"7004_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) Who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg 2016; 263(4):802\u20137.","journal-title":"Ann Surg"},{"issue":"10","key":"7004_CR22","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hieken TJ, Glazebrook KN, Boughey JC. Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges. Ann Surg Oncol 2017; 24(10):3011\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"7004_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"3","key":"7004_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","volume":"42","author":"V Galimberti","year":"2016","unstructured":"Galimberti V, Ribeiro Fontana SK, Maisonneuve P, et al. Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 2016; 42(3):361\u20138.","journal-title":"Eur J Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-7004-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-7004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-7004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:03:19Z","timestamp":1575072199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-7004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["7004"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-7004-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}